Cargando…
Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder
Central nervous system methotrexate-associated lymphoproliferative disorder (CNS-MTX-LPD) is rare, but its spontaneous regression has been observed in some patients after withdrawal of agents. We herein report three cases of primary CNS-MTX-LPD that received oral MTX for rheumatoid arthritis. Epstei...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841117/ https://www.ncbi.nlm.nih.gov/pubmed/35598995 http://dx.doi.org/10.2169/internalmedicine.9296-21 |
_version_ | 1784869761767702528 |
---|---|
author | Ueno, Hiroki Ohno, Narumi Abe, Takafumi Kimoto, Kazuki Matsuoka, Chika Giga, Mayumi Naito, Hiroyuki Kono, Tomoyuki Takasu, Miyuki Kidani, Naoya Yamasaki, Rie Ichimura, Koichi Nomura, Eiichi |
author_facet | Ueno, Hiroki Ohno, Narumi Abe, Takafumi Kimoto, Kazuki Matsuoka, Chika Giga, Mayumi Naito, Hiroyuki Kono, Tomoyuki Takasu, Miyuki Kidani, Naoya Yamasaki, Rie Ichimura, Koichi Nomura, Eiichi |
author_sort | Ueno, Hiroki |
collection | PubMed |
description | Central nervous system methotrexate-associated lymphoproliferative disorder (CNS-MTX-LPD) is rare, but its spontaneous regression has been observed in some patients after withdrawal of agents. We herein report three cases of primary CNS-MTX-LPD that received oral MTX for rheumatoid arthritis. Epstein-Barr virus and oligoclonal bands (OCBs) were positive, while proton magnetic resonance spectroscopy ((1)H-MRS) showed an elevated lipid peak and slightly elevated choline/N-acetylaspartate ratio in common. After MTX withdrawal, brain lesions showed spontaneous regression in all cases. Our patient's (1)H-MRS findings and OCBs may reflect a non-monoclonal lymphoproliferative histology as benign-type lesions in CNS-MTX-LPD. |
format | Online Article Text |
id | pubmed-9841117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-98411172023-01-26 Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder Ueno, Hiroki Ohno, Narumi Abe, Takafumi Kimoto, Kazuki Matsuoka, Chika Giga, Mayumi Naito, Hiroyuki Kono, Tomoyuki Takasu, Miyuki Kidani, Naoya Yamasaki, Rie Ichimura, Koichi Nomura, Eiichi Intern Med Case Report Central nervous system methotrexate-associated lymphoproliferative disorder (CNS-MTX-LPD) is rare, but its spontaneous regression has been observed in some patients after withdrawal of agents. We herein report three cases of primary CNS-MTX-LPD that received oral MTX for rheumatoid arthritis. Epstein-Barr virus and oligoclonal bands (OCBs) were positive, while proton magnetic resonance spectroscopy ((1)H-MRS) showed an elevated lipid peak and slightly elevated choline/N-acetylaspartate ratio in common. After MTX withdrawal, brain lesions showed spontaneous regression in all cases. Our patient's (1)H-MRS findings and OCBs may reflect a non-monoclonal lymphoproliferative histology as benign-type lesions in CNS-MTX-LPD. The Japanese Society of Internal Medicine 2022-05-21 2022-12-15 /pmc/articles/PMC9841117/ /pubmed/35598995 http://dx.doi.org/10.2169/internalmedicine.9296-21 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Ueno, Hiroki Ohno, Narumi Abe, Takafumi Kimoto, Kazuki Matsuoka, Chika Giga, Mayumi Naito, Hiroyuki Kono, Tomoyuki Takasu, Miyuki Kidani, Naoya Yamasaki, Rie Ichimura, Koichi Nomura, Eiichi Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder |
title | Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder |
title_full | Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder |
title_fullStr | Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder |
title_full_unstemmed | Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder |
title_short | Prognosis Prediction Using Magnetic Resonance Spectroscopy and Oligoclonal Bands in Central Nervous System Methotrexate-associated Lymphoproliferative Disorder |
title_sort | prognosis prediction using magnetic resonance spectroscopy and oligoclonal bands in central nervous system methotrexate-associated lymphoproliferative disorder |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841117/ https://www.ncbi.nlm.nih.gov/pubmed/35598995 http://dx.doi.org/10.2169/internalmedicine.9296-21 |
work_keys_str_mv | AT uenohiroki prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT ohnonarumi prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT abetakafumi prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT kimotokazuki prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT matsuokachika prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT gigamayumi prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT naitohiroyuki prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT konotomoyuki prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT takasumiyuki prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT kidaninaoya prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT yamasakirie prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT ichimurakoichi prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder AT nomuraeiichi prognosispredictionusingmagneticresonancespectroscopyandoligoclonalbandsincentralnervoussystemmethotrexateassociatedlymphoproliferativedisorder |